The NOSTONE treatment phase is finished with 93% participants completing the study according to protocol: a great result thanks to a great patients’ commitment!
In this clinical study, the efficacy of a drug will be tested in the recurrence prevention of calcium containing kidney stones.
In August 2015, the Swiss National Science Foundation launched the first call to fund Investigator Initiated Clinical Trials (IICT). One of these first round funded IICTs is the NOSTONE trial.
Click here to access the password protected section